Expected increase in prevalence of HCV-related cirrhosis and its complications in the United States: No effect of current antiviral treatment coverage? - 19/11/10
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
Articolo gratuito.
Si connetta per beneficiarne
Summary |
Davis et al. projected the future prevalence of chronic hepatitis C (CHC) and its complications in the United States, using a multicohort natural history model with a tree model. First, the model predicted that in 2010 many patients have already progressed to F4, including to decompensanted cirrhosis and HCC. Second, the model emphasized that cirrhosis and its complications are most common after 60 years old, regardless of when the infection occurred. Finally, the model showed that current treatment patterns will have little effect on the incidence of the complications hepatitis C.
Il testo completo di questo articolo è disponibile in PDF.Mappa
 | Commentary for GCB / Clinics and Research in Hepatology on “Aging of Hepatitis C Virus (HCV)-Infected Persons in the United States: A Multiple Cohort Model of HCV Prevalence and Disease Progression” by Davis et al., Gastroenterology 2010. |
Vol 34 - N° 11
P. 577-579 - Novembre 2010 Ritorno al numero
Articolo precedente
- Unusual left iliac fossa pain
- R. Arora, S.H. Chandrashekhara
- The HAMLET case: What can we learn from a misfolded protein that triggers tumour cell death?
- A. Lamazière, C. Wolf
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.